Cheng Richard, Tat Emily, Siegel Robert J, Arsanjani Reza, Hussaini Asma, Makar Moody, Mizutani Yukiko, Trento Alfredo, Kar Saibal
Division of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA, USA.
EuroIntervention. 2016 Oct 20;12(9):1176-1184. doi: 10.4244/EIJV12I9A191.
Mitral annular calcification (MAC) negatively influences outcomes in surgical mitral valve (MV) repair for mitral regurgitation (MR). However, there are no data on whether MAC impacts on outcomes of MitraClip percutaneous MV edge-to-edge repair. This study sought to investigate whether the presence of MAC impacts on the procedural success and durability of percutaneous transcatheter repair of MR using the MitraClip.
One hundred and seventy-three patients undergoing MitraClip repair for significant MR were studied. Patients with moderate-or-severe MAC (n=28) were compared to those with no-or-mild MAC. Post-procedural MR severity was not different (p=0.642) and MR reduction to moderate-or-less was equally high in patients with moderate-or-severe MAC (100%) and those without (96.7%), p=1.000. At one year, MR severity was not different (p=0.831), and there was no difference in the repair durability when comparing patients with moderate-or-severe MAC (93.8%) to those without (90.6%), p=1.000. All patients with moderate-or-severe MAC assessed at one year were in NYHA functional Class I-II and had haemodynamic improvements with a decrease in pulmonary artery systolic pressure (-6.5±13.1 mmHg), p=0.021, and end-diastolic left ventricular internal diameter (-3.9±6.5 mm), p=0.034, not different to those achieved by patients without MAC (both p>0.100).
Moderate-or-severe MAC scored by echocardiography and confirmed on fluoroscopy was not associated with decreased procedural success or durability of repair. Patients with moderate-or-severe MAC had improvements in clinical symptoms and haemodynamics, as well as decreased left ventricular dimensions.
二尖瓣环钙化(MAC)对二尖瓣反流(MR)的外科二尖瓣(MV)修复结果有负面影响。然而,尚无关于MAC是否影响MitraClip经皮MV缘对缘修复结果的数据。本研究旨在调查MAC的存在是否影响使用MitraClip经皮经导管修复MR的手术成功率和耐久性。
对173例接受MitraClip修复严重MR的患者进行了研究。将中度或重度MAC患者(n = 28)与无或轻度MAC患者进行比较。术后MR严重程度无差异(p = 0.642),中度或重度MAC患者(100%)和无MAC患者(96.7%)将MR降至中度或更低的比例同样高,p = 1.000。在1年时,MR严重程度无差异(p = 0.831),将中度或重度MAC患者(93.8%)与无MAC患者(90.6%)进行比较时,修复耐久性无差异,p = 1.000。所有在1年时评估的中度或重度MAC患者均处于纽约心脏协会(NYHA)心功能I-II级,血流动力学有所改善,肺动脉收缩压降低(-6.5±13.1 mmHg),p = 0.021,舒张末期左心室内径减小(-3.9±6.5 mm),p = 0.034,与无MAC患者所达到的情况无差异(两者p>0.100)。
经超声心动图评分并经透视确认的中度或重度MAC与手术成功率降低或修复耐久性降低无关。中度或重度MAC患者的临床症状和血流动力学有所改善,左心室尺寸减小。